Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Bifidobacterium bifidum + Inulin-type fructans (ITF) / Inulin + Lacticaseibacillus casei + Lactobacillus acidophilus & Type 2 diabetes (T2D)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Clinical data

In the randomized, double-blinded, placebo-controlled clinical trial identified as IRCT2017090133941N1, researchers found that a 12-week supplementation with Bifidobacterium bifidum combined with Inulin-type fructans (ITF) or Inulin, along with Lacticaseibacillus casei and Lactobacillus acidophilus, resulted in positive outcomes. These outcomes included improvements in glycemic control, as well as reductions in biomarkers of inflammation and oxidative stress among diabetic patients undergoing hemodialysis.

References

(1) Soleimani et al. 2019 Probiotics & Antimicro Prot 11: 1248-1256

References (Sources)

The Effects of Synbiotic Supplementation on Metabolic Status in Diabetic Patients Undergoing Hemodialysis: a Randomized, Double-Blinded, Placebo-Controlled Trial
Soleimani et al. 2019 Probiotics & Antimicro Prot 11: 1248-1256

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!